When Vermont legislators considered a bill requiring mandatory labels on genetically modified food, they ran into an obstacle that had nothing to do with science or public opinion. Monsanto, the agricultural biotechnology giant, threatened to sue the state if the legislation passed. The episode became a case study in how corporate legal power can override democratic processes.
Overwhelming Support Met with Legislative Paralysis
Vermont’s proposed GMO labeling bill, H-722, had the backing of a clear majority on the House Agriculture Committee, with six of eleven members supporting passage. Public response was equally decisive — thousands of emails, calls, and letters flooded legislators’ offices, making it one of the most popular bills since Vermont’s Civil Unions debate in 1999-2000.
Yet despite this support, the bill stalled. Committee members called for additional public hearings and delayed voting procedures, with critics observing that the strategy appeared designed to run out the clock before the legislative session ended in early May.
Corporate Litigation as a Political Weapon
The shift in legislative momentum traced directly to Monsanto’s legal threat. A company representative communicated to Vermont officials that the corporation would pursue litigation if the labeling requirement became law. Several legislators who had previously championed the bill publicly reversed course, citing concerns about Vermont being the first state to face Monsanto in court without support from other states.
This was not a new tactic. Monsanto had employed lawsuits and litigation threats for two decades to prevent labeling of genetically engineered foods and to pressure farmers into purchasing its proprietary seeds and growth hormones.
The rBGH Precedent
Vermont had encountered Monsanto’s legal strategy before. In 1994, the state became the first to require mandatory labeling on dairy products from cows injected with recombinant Bovine Growth Hormone (rBGH). Monsanto challenged the requirement in federal court and prevailed, with a judge ruling that dairy companies had a First Amendment right not to disclose whether their cows received the hormone — despite the fact that rBGH was linked to health problems in cattle and banned in the European Union and Canada.
That precedent cast a long shadow over the GMO labeling debate, giving legislators a concrete example of what a legal challenge from Monsanto might look like.
California’s Ballot Initiative Response
The dynamics in Vermont illustrated why activists in California chose to bypass the legislative process entirely. Recognizing that Monsanto’s lobbying influence extended to most state capitals, organizers collected over 850,000 signatures to place a citizens’ initiative on the November 2012 ballot. The California Right to Know Act proposed mandatory GMO labeling and a ban on marketing GMO-containing products as “natural.”
The ballot initiative approach removed state legislators from the equation, putting the decision directly in voters’ hands and denying Monsanto its most effective pressure point.
Science vs. Corporate Messaging
During Vermont’s committee hearings, expert testimony challenged industry claims about GMO safety. Scientists from organizations like the Consumers Union presented evidence questioning the adequacy of safety testing for genetically modified organisms and argued that consumers had a fundamental right to know what was in their food.
The core tension was not really about labeling logistics or legal technicalities. It was about whether elected officials would act on constituent demand and scientific testimony, or defer to the litigation threats of a corporation with the resources to make good on them. In Vermont’s case, the corporation’s threat proved more persuasive than the public’s voice.
